Zerion and Insud to develop Dispersome formulations of drugs
Pharmaceutical Technology
AUGUST 30, 2022
Under the deal, Zerion will handle the development of Dispersome formulations of marketed drugs. The finished product dosage form, clinical development and the final products’ marketing and sales across the globe will be handled by Insud. . All the clinical and other development expenses will be handled by Insud.
Let's personalize your content